Association between anti-β2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases
Abstract
Glomerular microthrombosis (GMT) is a common vascular change in patients with lupus nephritis (LN). The mechanism underlying GMT is still unknown. In our previous study, we found that the level of IgG anti-β2 glycoprotein I (β2GPI) antibodies was higher in the LN-GMT group than in the LN-non-GMT group, which indicated that anti-β2GPI antibodies may play a role in GMT formation. Many studies have demonstrated that the activation of the classical complement pathway may play a critical role in fetal loss and aPL-induced thrombosis formation. To investigate whether complement activation plays a role in GMT formation and to evaluate its relationship with aPL, we prospectively investigated deposition of C4d in 155 renal biopsy specimens of LN patients. The results revealed a strong relationship between the intensity of glomerular C4d staining and the presence of microthrombi (p < 0.001). The detection rate of IgG anti-β2GPI antibodies was higher in the LN-GMT group than in the LN-non-GMT group (p < 0.05). Further, the intensity of glomerular C4d staining was significantly related with IgG anti-β2GPI antibodies (p < 0.05). The results of our study suggest that anti-β2GPI antibodies may play a role in GMT formation, and this process might involve complement activation. Lupus (2010) 19, 1195—1203.
Get full access to this article
View all access and purchase options for this article.
References
Mok CC Prognostic factors in lupus nephritis. Lupus 2005; 14: 39-44.
Cameron JS Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.
Jain R., Chartash E., Susin M., Furie R. Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 1994; 24: 173-182.
Hughson MD, Nadasdy T., McCarty GA, Sholer C., Min KW, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992; 20: 150-158.
Loizou S., Samarkos M., Norsworthy PJ, Cazabon JK, Walport MJ, Davies KA Significance of anticardiolipin and anti-beta2-glycoprotein I antibodies in lupus nephritis. Rheumatology (Oxford ) 2000; 39: 962-968.
Nochy D., Daugas E., Huong DL, Piette JC, Hill G. Kidney involvement in the antiphospholipid syndrome. J Autoimmun 2000; 15: 127-132.
Tektonidou MG, Sotsiou F., Nakopoulou L., Vlachoyiannopoulos PG, Moutsopoulos HM Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004; 50: 2569-2579.
Bhandari S., Harnden P., Brownjohn AM, Turney JH Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 1998; 91: 401-409.
Cohen D., Koopmans M., Kremer Hovinga IC, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 2008; 58: 2460-2469.
Gong R., Liu Z., Li L. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/ clinical factors. Arthritis Rheum 2007; 56: 1608-1617.
Miranda JM, Garcia-Torres R., Jara LJ, Medina F., Cervera H., Fraga A. Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 1994; 3: 25-29.
Zheng H., Chen Y., Ao W., et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther 2009; 11: R93.
Pierangeli SS, Girardi G., Vega-Ostertag M., Liu X., Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005; 52: 2120-2124.
Pierangeli SS, Chen PP, Gonzalez EB Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006; 13: 366-375.
Navratil JS, Manzi S., Kao AH, et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum 2006; 54: 670-674.
Peerschke EI, Yin W., Alpert DR, Roubey RA, Salmon JE, Ghebrehiwet B. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus 2009; 18: 530-538.
Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation . Kidney Int 1996; 50: 1464-1475.
Racusen LC, Colvin RB, Solez K., et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation . J Reprod Immunol 2008; 77: 51-56.
Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695.
Wakai S., Matsumura O., Koike T., Maruyama N., Yumura W. Anti-cardiolipin antibody and renal microthrombi in lupus nephritis. Ryumachi 1991; 31: 481-487.
Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance . Medicine (Baltimore) 1981; 60: 71-86.
Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
Giannakopoulos B., Passam F., Rahgozar S., Krilis SA Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109: 422-430.
Truedsson L., Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007; 40: 560-566.
Yang DH, Chang DM, Lai JH, Lin FH, Chen CH Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48: 1083-1087.
Pierangeli SS, Colden-Stanfield M., Liu X., Barker JH, Anderson GL, Harris EN Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
Nangaku M., Quigg RJ, Shankland SJ, Okada N., Johnson RJ, Couser WG Overexpression of Crry protects mesangial cells from complement-mediated injury . J Am Soc Nephrol 1997; 8: 223-233.
Fischetti F., Durigutto P., Pellis V., et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor . Blood 2005; 106: 2340-2346.
Seshan SV, Franzke CW, Redecha P., Monestier M., Mackman N., Girardi G. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood 2009 ; 114: 1675-1683.
Suzuki T., Horita S., Kadoya K., et al. C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol 2007; 11: 287-291.
Zwirner J., Felber E., Herzog V., Riethmuller G., Feucht HE Classical pathway of complement activation in normal and diseased human glomeruli . Kidney Int 1989; 36: 1069-1077.
Kusunoki Y., Itami N., Tochimaru H., Takekoshi Y., Nagasawa S., Yoshiki T. Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron 1989; 51: 17-19.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: May 26, 2010
Issue published: September 2010
Keywords
PubMed: 20504833
Authors
Metrics and citations
Metrics
Article usage*
Total views and downloads: 48
*Article usage tracking started in December 2016
Altmetric
See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 35 view articles Opens in new tab
Crossref: 37
- Complement C4d as a biomarker for systemic lupus erythematosus and lup...
- Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Synd...
- Anticardiolipin Antibody Plays a More Important Role Than Anti-β2-Glyc...
- Anti‐C1q antibodies in lupus nephritis children with glo...
- Renal C4d is a potential biomarker of disease activity and severity in...
- Thrombotic microangiopathy mediates poor prognosis among lupus nephrit...
- Increased risk of acute and chronic microvascular renal lesions associ...
- The role of anticomplement therapy in lupus nephritis
- C4d as a Screening Tool and an Independent Predictor of Clinical Outco...
- Autoantibodies and Kidney Diseases
- Effect of sera from lupus patients on the glomerular endothelial fibri...
- The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Pa...
- Association of antiphospholipid antibodies with clinical activity and ...
- Alternative complement pathway activation in thrombotic microangiopath...
- Autoantibodies and Kidney Diseases
- Antiphospholipid antibodies in patients with proliferative and membran...
- Renal microvascular lesions in lupus nephritis
- A high-risk laboratory profile of antiphospholipid antibodies and thro...
- Association between antiphospholipid antibodies and factor Bb in lupus...
- Epidemiology and Pathophysiology of Glomerular C4d Staining in Native ...
- Clinical profiles and risk assessment in patients with antiphospholipi...
- Thrombotic Microangiopathies with Rheumatologic Involvement
- Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
- Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antip...
- IgG/IgM antiphospholipid antibodies present in the classification crit...
- Complement activation and effect of eculizumab in scleroderma renal cr...
- Complement Factor C4d Is a Common Denominator in Thrombotic Microangio...
- Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangi...
- Diverse vascular lesions in systemic lupus erythematosus and clinical ...
- Renal Arteriolar C4d Deposition
- Inclusion of renal vascular lesions in the 2003 ISN/RPS system for cla...
- Glomerular C4d Staining Can Be an Indicator of Disease Activity in Lup...
- The spectrum of renal thrombotic microangiopathy in lupus nephritis
- Association of chemokine CXCL12-3′G801A polymorphism with systemic lup...
- Pros and cons for C4d as a biomarker
- Basic and Translational Concepts of Immune-Mediated Glomerular Disease...
- Clinicopathologic correlations of renal microthrombosis and inflammato...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
